ArticleACS medicinal chemistry letters2026
Novel Tetrahydropyridinyl-6,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.
Ram W Sabnis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.